{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:40:29Z","timestamp":1785253229537,"version":"3.55.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>The prognostic implications of the immunophenotype of the tumor-infiltrating lymphocytes (TILs) in primary cutaneous melanoma are well known. In recent years, the study of this immunophenotype has also resulted in immunotherapeutic consequences. The aims of this study were to characterize the subpopulations of TILs in primary cutaneous melanoma, in cases with and without metastasis, as well as the neovascularization associated with the primary neoplasm, and its influence on the development of metastasis. To this end, the immunophenotype of TILs and the neovascularization of 80 patients with primary cutaneous melanoma (40 each with metastatic and non-metastatic melanoma) were analyzed by immunohistochemistry for CD3, CD4, CD8, FOXP3, PD-1, CD31, and D2-40 antibodies. We found that higher frequencies of TILs with brisk pattern, and CD4<jats:sup>+<\/jats:sup>, CD8<jats:sup>+<\/jats:sup>, and CD20<jats:sup>+<\/jats:sup> cells in TILs, and a lower frequency of CD31<jats:sup>+<\/jats:sup> vessels were histopathological features associated with better prognosis in primary cutaneous melanoma. Our results support the notion that the immunohistochemical study of TILs and neovascularization in primary cutaneous melanoma may be helpful tools for identifying patients at increased risk of metastasis development.<\/jats:p>","DOI":"10.1097\/dad.0000000000001907","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T18:00:20Z","timestamp":1611770420000},"page":"811-818","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Immunophenotypic Differences in Tumor-Infiltrating Lymphocytes and Neovascularization Between Primary Cutaneous Melanoma With and Without Metastasis: An Immunohistochemical Study of 80 Cases"],"prefix":"10.1097","volume":"43","author":[{"given":"Irene","family":"Salg\u00fcero","sequence":"first","affiliation":[{"name":"Department of Dermatology, Puerta de Hierro University Hospital, Universidad Aut\u00f3noma, Majadahonda, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaston","family":"Roust\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Puerta de Hierro University Hospital, Universidad Aut\u00f3noma, Majadahonda, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Requena","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Su\u00e1rez","sequence":"additional","affiliation":[{"name":"Department of Pathology, Puerta de Hierro University Hospital, Universidad Aut\u00f3noma, Majadahonda, Madrid, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Garc\u00eda-Fresnadillo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Puerta de Hierro University Hospital, Universidad Aut\u00f3noma, Majadahonda, Madrid, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ignacio","family":"Redondo","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, CEU Cardenal Herrera University, Valencia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"N\u00e1jera","sequence":"additional","affiliation":[{"name":"Department of Pathology, Puerta de Hierro University Hospital, Universidad Aut\u00f3noma, Majadahonda, Madrid, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"key":"R1-20250616","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature."},{"key":"R2-20250616","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N Engl J Med."},{"key":"R3-20250616","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1001\/jama.2014.6096","article-title":"Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial","volume":"311","author":"Carvajal","year":"2014","journal-title":"JAMA."},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","article-title":"Model predicting survival in stage I melanoma based on tumor progression","volume":"81","author":"Clark","year":"1989","journal-title":"J Natl Cancer Inst."},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1309\/G6EK-Y6EH-0LGY-6D6P","article-title":"Histologic classification of tumor-infiltrating lymphocytes in primary cutaneous malignant melanoma. A study of interobserver agreement","volume":"115","author":"Busam","year":"2001","journal-title":"Am J Clin Pathol."},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/bjc.2011.189","article-title":"The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis","volume":"105","author":"Gooden","year":"2011","journal-title":"Br J Cancer."},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"1593806","DOI":"10.1080\/2162402X.2019.1593806","article-title":"Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis","volume":"8","author":"Fu","year":"2019","journal-title":"Oncoimmunology."},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/labinvest.3700389","article-title":"Tumor-infiltrating T lymphocytes: friends or foes?","volume":"86","author":"Yu","year":"2006","journal-title":"Lab Invest."},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1158\/1078-0432.CCR-14-3073","article-title":"Characterization of PD-L1 expression and associated T-cell infiltrates in metastatic melanoma samples from variable anatomic sites","volume":"21","author":"Kluger","year":"2015","journal-title":"Clin Cancer Res."},{"key":"R10-20250616","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fimmu.2014.00295","article-title":"Impact of inflammatory cytokines on effector and memory CD8+ T cells","volume":"5","author":"Kim","year":"2014","journal-title":"Front Immunol."},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000362332","article-title":"The immune microenvironment: a major player in human cancers","volume":"164","author":"Fridman","year":"2014","journal-title":"Int Arch Allergy Immunol."},{"key":"R12-20250616","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science."},{"key":"R13-20250616","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat Rev Immunol."},{"key":"R14-20250616","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat Rev Clin Oncol."},{"key":"R15-20250616","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/pcmr.12371","article-title":"Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma","volume":"28","author":"Lad\u00e1nyi","year":"2015","journal-title":"Pigment Cell Melanoma Res."},{"key":"R16-20250616","first-page":"1115","article-title":"Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma","volume":"18","author":"Miracco","year":"2007","journal-title":"Oncol Rep."},{"key":"R17-20250616","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/bjd.12641","article-title":"High expression of FOXP3 in primary melanoma is associated with tumour progression","volume":"170","author":"Gerber","year":"2014","journal-title":"Br J Dermatol."},{"key":"R18-20250616","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12253-010-9254-x","article-title":"FOXP3+ cell density in primary tumor has no prognostic impact in patients with cutaneous malignant melanoma","volume":"16","author":"Lad\u00e1nyi","year":"2010","journal-title":"Pathol Oncol Res."},{"key":"R19-20250616","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1158\/0008-5472.CAN-11-3218","article-title":"Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma","volume":"72","author":"Erdag","year":"2012","journal-title":"Cancer Res."},{"key":"R20-20250616","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/modpathol.2015.110","article-title":"Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases","volume":"28","author":"Kakavand","year":"2015","journal-title":"Mod Pathol."},{"key":"R21-20250616","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","article-title":"Regulatory T cells in cancer immunosuppression\u2014implications for anticancer therapy","volume":"16","author":"Togashi","year":"2019","journal-title":"Nat Rev Clin Oncol."},{"key":"R22-20250616","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1158\/0008-5472.CAN-14-2819","article-title":"Novel mechanism of macrophage-mediated metastasis revealed in a zebrafish model of tumor development","volume":"75","author":"Wang","year":"2015","journal-title":"Cancer Res."},{"key":"R23-20250616","doi-asserted-by":"crossref","first-page":"127ra37","DOI":"10.1126\/scitranslmed.3003689","article-title":"Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape","volume":"4","author":"Taube","year":"2012","journal-title":"Sci Transl Med."},{"key":"R24-20250616","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature."},{"key":"R25-20250616","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-13-3271","article-title":"Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy","volume":"20","author":"Taube","year":"2014","journal-title":"Clin Cancer Res."},{"key":"R26-20250616","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0002-9440(10)64328-3","article-title":"Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival","volume":"162","author":"Dadras","year":"2003","journal-title":"Am J Pathol."},{"key":"R27-20250616","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/bjd.12688","article-title":"Blood microvessel density, lymphatic microvessel density and lymphatic invasion in predicting melanoma metastases: systematic review and meta-analysis","volume":"170","author":"Pastushenko","year":"2014","journal-title":"Br J Dermatol."},{"key":"R28-20250616","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0140-6736(94)90557-6","article-title":"Tumour vascularity is not a prognostic factor for cutaneous melanoma","volume":"344","author":"Barnhill","year":"1994","journal-title":"Lancet."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000001907","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T19:02:55Z","timestamp":1750100575000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000001907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000001907","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,27]]}}}